To verify the influence of the TLR4/NF-kB signaling pathway on inflammatory factors and growth factors in diabetic retinopathy, we used the TLR4/NF-kB signaling inhibitor TAK-242. This evidence concerns the gene TLR4 and diabetic retinopathy.